Furthermore, combination therapy trials exploring the synergistic effects of GLP-1RAs with biologics could uncover new approaches for treatment, enhancing the management both metabolic and immunologic aspects in PsA
According to the World Obesity Atlas 2023, the global prevalence of obesity is expected to rise from 14% in 2020 to 24% by 2035
Editorial refresh Online Doctor vs Endocrinologist for GLP now carries extra 2026 context around semaglutide, tirzepatide, cash-pay pricing, safety signals, online, doctor, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation
[PMC free article][PubMed] [CrossRef] Winter SC
Clinical trials indicate that Tirzepatide may produce slightly more weight loss on average, but individuals will respond variably based on their underlying metabolism